which are under patent protection in India. The Indian prices of DPP-4 inhibitors are higher than those of other drugs in … the same segment, but only a fraction of the price in the U.S. and other developed countries (i.e., the patent holders … practice international differential pricing). The patent holders also license the products out voluntarily to local …

The use of “pay-for-delay” settlements in patent litigation – in which a branded manufacturer and generic entrant … settle a Paragraph IV patent challenge and agree to forestall entry – has come under considerable scrutiny in recent years … instruments include standard measures of patent strength and a measure of settlement legality based on a split between several …

The use of “pay-for-delay” settlements in patent litigation – in which a branded manufacturer and generic entrant … settle a Paragraph IV patent challenge and agree to forestall entry – has come under considerable scrutiny in recent years … instruments include standard measures of patent strength and a measure of settlement legality based on a split between several …

The use of so-called “pay-for-delay” settlements in patent litigation – in which a branded manufacturer and generic … entrant settle a Paragraph IV patent challenge and agree to forestall entry – has come under considerable scrutiny in recent … settlements we estimate the model using instrumental variables. Our instruments include standard measures of patent strength and a …

The use of "pay-for-delay" settlements in patent litigation - in which a branded manufacturer and generic entrant … settle a Paragraph IV patent challenge and agree to forestall entry - has come under considerable scrutiny in recent years … instruments include standard measures of patent strength and a measure of settlement legality based on a split between several …